Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

Add to Watch List
Set Alert
5.46
Data as of May 17
 +0.05 / +0.92%
Today’s Change
2.30
Today|||52-Week Range
6.85
+30.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$281.8M

Company Description

Sunesis Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company primarily engages in development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Its efforts are currently focused primarily on the development of vosaroxin for the treatment of acute myeloid leukemia. The company's primary activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. Sunesis Pharmaceuticals was founded on February 10, 1998 and is headquartered in South San Francisco, CA.

Contact Information

Sunesis Pharmaceuticals, Inc.
395 Oyster Point Boulevard
South San Francisco California 94080
P:(650) 266-3500
Investor Relations:
(650) 266-3717

Employees

Shareholders

Other institutional43.57%
Mutual fund holders19.40%
Individual stakeholders0.89%

Top Executives

Daniel N. Swisher, Jr., MBAPresident, Chief Executive Officer & Director
Eric H. Bjerkholt, MBACFO, Secretary & EVP-Corporate Development
Adam R. Craig, PhD, MBAChief Medical officer & Executive VP-Development
Judith A. Fox, PhDVice President-Product & Preclinical Development
Gene C. JamiesonVP-Chemistry, Manufacturing & Controls

To view my watchlist

Not a member yet?

Sign up now for a free account

jobs by SimplyHired

Search for jobs

Search All Jobs from Across the Web

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.
© 2013 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Ad choices .